Rate of Low-Density-Lipoprotein Cholesterol (LDL-C) target attainment in patients on cholesterol lowering therapies for coronary artery disease secondary prevention.

  • Jacobson, Peter (PI)
  • Ahmed, Zaeem Z. (PI)
  • Brandt-casadevall, Conception (CoPI)
  • Krompecher, Thomas (PI)
  • Mangin, Patrice Jean Dominique (CoPI)
  • Sevgur, Serperi B. (PI)

Project: Research project

Project Details

Description

Hypercholesterolemia, the presence of high levels of cholesterol lipoprotein molecules in blood, contributed to 3% of disease burden in Australia in 2015. It is a major modifiable risk factor for coronary artery disease (CAD) and other forms of atherosclerotic vascular disease. Cholesterol lowering therapy (CLT) is one management option offered/prescribed to patients to modify this risk factor.

StatusFinished
Effective start/end date10/1/01 → 8/9/21

Funding

  • Social Sciences and Humanities Research Council of Canada: US$95,083.00

ASJC Scopus Subject Areas

  • Psychiatry and Mental health
  • Social Sciences(all)
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)
  • Pathology and Forensic Medicine
  • Physiology (medical)
  • Law

Access Project